Clinical Trial Update: Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of administering Gardasil concurrently with a combined Diphtheria/Tetanus/Pertussis vaccine and a Meningococcal conjugate va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Diphtheria
• Genital Warts
• Meningitis
• Pertussis
• Tetanus

Drugs mentioned

• Diphtheria-tetanus-pertussis vaccine (Diphtheria, Tetanus and Pertussis vaccine)
• Gardasil (human papillomavirus vaccine)
• Meningococcal conjugate vaccine (Meningococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Glandular and Epithelial, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2009-07-13